Search
Displaying results 1 to 10 out of 2,743
-
Hormonal contraceptive methods for women at high risk of HIV and living with HIV : 2014 guidance statement
Home › Activities & Resources › Hormonal contraceptive methods for women at high risk of HIV and living with HIV : 2014 guidance statement
Hormonal contraceptive methods for women at high risk of HIV and living with HIV : 2014 guidance statement Publication date: 2014 During 9–12 March 2014, the World Health Organization (WHO) convened…
-
USAID List of approved HIV & AIDS test kits
Home › Activities & Resources › USAID List of approved HIV & AIDS test kits
USAID List of approved HIV & AIDS test kits Publication date: 2008 USAID List of Approved HIV/AIDS Rapid Test Kits - April 1, 2008 Test Kit Name Supplier Approved by 1. Aware™ HIV-1/2 BSP Calypte Biomedical* USAID 2. Bioline HIV 1/2 3.0 Standard Diagnostics USAID 3. Bionor™ HIV-1&2 Bionor A/S USAID 4. Bundi™ Rapid HIV 1/2 Bundi International Diagnostics Ltd. USAID 5. Calypte® Aware™ HIV-1/2 OMT Calypte Biomedical Corp.* USAID 6. Capillus™ HIV-1/HIV-2 Trinity Biotech USAID 7. Care Start™ HIV 1-2-O Access Bio, Inc.* USAID 8. Clearview® COMPLETE HIV1/2 Inverness Medical Innovations, Inc.* USAID (formerly SURE…
-
MOH Brief 6 A Contraceptive Option for HIV-Positive Clients
Home › Activities & Resources › MOH Brief 6 A Contraceptive Option for HIV-Positive Clients
MOH Brief 6 A Contraceptive Option for HIV-Positive Clients Publication date: 2003 Recommendations for use An HIV-positive woman who wants to avoid pregnancy has the same need for safe and effective contraception as any other woman. According to the 2004 revised World Health Organization’s medical eligibility criteria, HIV and high risk of HIV are “Category 2” conditions for IUCD use. For Category 2 conditions, the method can generally be used, but careful follow-up may be required. Considering its effectiveness and long-term contraceptive protection, the IUCD can be an appropriate choice for HIV…
-
IUCD Method Brief 6: A Contraceptive Option for HIV-Positive Clients
rhsupplies.org/uploads/tx_rhscpublications/MOH Kenya_IUD Br…
Recommendations for use An HIV-positive woman who wants to avoid pregnancy has the same need for safe and effective contraception as any other woman. According to the 2004 revised World Health Organization’s medical eligibility criteria, HIV and high risk of HIV are “Category 2” conditions for IUCD use. For Category 2 conditions, the method can generally be used, but careful follow-up may be required. Considering its effectiveness and long-term contraceptive protection, the IUCD can be an appropriate choice for HIV-positive women, provided they have continuing access to medical services…
-
Family Planning and HIV Integration in Malawi: A Policy Analysis
Home › Activities & Resources › Family Planning and HIV Integration in Malawi: A Policy Analysis
Family Planning and HIV Integration in Malawi: A Policy Analysis Publication date: 2015 FAMILY PLANNING AND HIV INTEGRATION IN MALAWI A Policy Analysis September 2015 This publication was prepared by Laili Irani, Sara Pappa, and Pierre Dindi of the Health Policy Project. HEALTH POL ICY P R O J E C T Suggested citation: Irani, L., S. Pappa, and P. Dindi. 2015. Fam ily Planning and HIV Integration…
-
Family Planning and HIV Integration in Malawi: A Policy Analysis
rhsupplies.org/uploads/tx_rhscpublications/Family_Planning_…
FAMILY PLANNING AND HIV INTEGRATION IN MALAWI A Policy Analysis September 2015 This publication was prepared by Laili Irani, Sara Pappa, and Pierre Dindi of the Health Policy Project. HEALTH POL ICY P R O J E C T Suggested citation: Irani, L., S. Pappa, and P. Dindi. 2015. Fam ily Planning and HIV Integration in Malawi: A Policy Analysis.…
-
PMTCT A Decision Model for Evaluating Strategies to Prevent Mother-to-Child Transmission of HIV
Home › Activities & Resources › PMTCT A Decision Model for Evaluating Strategies to Prevent Mother-to-Child Transmission of HIV
PMTCT A Decision Model for Evaluating Strategies to Prevent Mother-to-Child Transmission of HIV Publication date: 2002 By Lori Bollinger John Stover Katharine Cooper-Arnold The Futures Group International A Decision Model for Evaluating Strategies to Prevent Mother-to-Child Transmission of HIV Spectrum System of Policy Models The POLICY Project Spectrum PMTCT PMTCT Version 1 A Decision Model for Evaluating Strategies to Prevent Mother-to- Child Transmission of HIV January, 2002 Spectrum System of Policy Models Lori Bollinger John Stover Katharine…
-
Estimating the Costs of Nonintegrated and Integrated Family Planning and HIV Facility Services in Malawi
Home › Activities & Resources › Estimating the Costs of Nonintegrated and Integrated Family Planning and HIV Facility Services in Malawi
Estimating the Costs of Nonintegrated and Integrated Family Planning and HIV Facility Services in Malawi Publication date: 2015 This publication was prepared by Adebiyi Adesina, Taryn Couture, and Erin McGinn of the Health Policy Project. ESTIMATING THE COSTS OF NONINTEGRATED AND INTEGRATED FAMILY PLANNING AND HIV FACILITY SERVICES IN MALAWI September 2015 HEALTH POL ICY P R O J E C T Suggested citation: Adesina, A., T. Couture, and E. McGinn. 2015. Estimating the Costs of Nonintegrated and Integrated Fam ily Planning and HIV Facility Services in Malawi. Washington, DC: Futures Group, Health Policy…
-
Integrated Family Planning and HIV Services for Youth: Applying Study Findings in the COVID-19 Pandemic
Home › Activities & Resources › Integrated Family Planning and HIV Services for Youth: Applying Study Findings in the COVID-19 Pandemic
Integrated Family Planning and HIV Services for Youth: Applying Study Findings in the COVID-19 Pandemic Publication date: 2021 INTEGRATED FAMILY PLANNING AND HIV SERVICES FOR YOUTH: APPLYING ECHO…
-
Integrated Family Planning HIV Services for Youth
rhsupplies.org/uploads/tx_rhscpublications/Integrated_Famil…
INTEGRATED FAMILY PLANNING AND HIV SERVICES FOR YOUTH: APPLYING ECHO STUDY FINDINGS IN THE COVID-19 PANDEMIC JULY 2020 The ECHO Study: Landmark Research Provides a Relevant Roadmap to Change for SRHR Programs1 Just over one year ago, the results of the Evidence for Contraceptive Options and HIV Outcomes Study (ECHO) study were released. ECHO was conducted to address years of concern that people who use the contraceptive depot medroxyprogesterone acetate (DMPA) might be at increased risk of HIV infection. The study found that are that there was no substantial difference in HIV risk among women…